RE:Drop and PopThey are sitting on something here, and from the looks of how we went from 18-20 to 34 and back to 18, completely wiping out everything related to this deal, tells me that:
1) the trading base (not investing base) took whatever profit off the table they could
2) based upon the short sales covered, they are leveraging the sentiment and historical reputation of the R&F deal to make it sound like the Abbvie deal is "nothing", when in fact it is not.
Saying this deal is the biggest deal they have ever signed, one needs to tally the total deal from Wanbang including the unrealized portion to compare to.
Here is another clear statement from the interview:
Congratulation on the AbbVie deal! So, What does this mean for Sirona Biochem?
HV: Our deal with AbbVie is a game-changer for Sirona Biochem. It is the biggest-ever deal we have signed to date. It took us over a decade to perfect our technology platform, and this deal validates all our hard work. Having AbbVie as a partner places us in the big leagues, and we are in line for considerable revenue flow for years to come. I see great potential in collaborating with AbbVie in developing future products. This is only the beginning of our vision for Sirona.